300 related articles for article (PubMed ID: 34162597)
1. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Chavatza K; Kostopoulou M; Nikolopoulos D; Gioti O; Togia K; Andreoli L; Aringer M; Boletis J; Doria A; Houssiau FA; Jayne D; Mosca M; Svenungsson E; Tincani A; Bertsias G; Fanouriakis A; Boumpas DT
Ann Rheum Dis; 2021 Sep; 80(9):1175-1182. PubMed ID: 34162597
[TBL] [Abstract][Full Text] [Related]
2. Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus.
Taheri N; Mageau A; Chauveheid MP; Dossier A; Farhi F; Mendes C; Papo T; Goulenok T; Sacre K
Eur J Intern Med; 2023 Mar; 109():68-72. PubMed ID: 36585323
[TBL] [Abstract][Full Text] [Related]
3. Update οn the diagnosis and management of systemic lupus erythematosus.
Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
[TBL] [Abstract][Full Text] [Related]
4. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Almeida-Brasil CC; Hanly JG; Urowitz M; Clarke AE; Ruiz-Irastorza G; Gordon C; Ramsey-Goldman R; Petri M; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken C; Isenberg D; Rahman A; Manzi S; Jacobsen S; Lim S; van Vollenhoven RF; Nived O; Jönsen A; Kamen DL; Aranow C; Sanchez-Guerrero J; Gladman DD; Fortin PR; Alarcón GS; Merrill JT; Kalunian K; Ramos-Casals M; Steinsson K; Zoma A; Askanase A; Khamashta MA; Bruce IN; Inanc M; Abrahamowicz M; Bernatsky S
Ann Rheum Dis; 2022 Mar; 81(3):370-378. PubMed ID: 34911705
[TBL] [Abstract][Full Text] [Related]
5. A quality indicator set for systemic lupus erythematosus.
Yazdany J; Panopalis P; Gillis JZ; Schmajuk G; MacLean CH; Wofsy D; Yelin E;
Arthritis Rheum; 2009 Mar; 61(3):370-7. PubMed ID: 19248127
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators.
Gillis JZ; Panopalis P; Schmajuk G; Ramsey-Goldman R; Yazdany J
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):17-30. PubMed ID: 20734353
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators.
Demas KL; Keenan BT; Solomon DH; Yazdany J; Costenbader KH
Semin Arthritis Rheum; 2010 Dec; 40(3):193-200. PubMed ID: 20378155
[TBL] [Abstract][Full Text] [Related]
8. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic.
Quinzanos I; Davis L; Keniston A; Nash A; Yazdany J; Fransen R; Hirsh JM; Zell J
Lupus; 2015 Feb; 24(2):203-9. PubMed ID: 25267076
[TBL] [Abstract][Full Text] [Related]
9. Seventy years after Hench's Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus.
Ruiz-Irastorza G; Ugarte A; Ruiz-Arruza I; Khamashta M
Lupus; 2020 Sep; 29(10):1155-1167. PubMed ID: 32539657
[TBL] [Abstract][Full Text] [Related]
10. Quality indicators and satisfaction with care in patients with systemic lupus erythematosus.
Serna-Peña G; Castillo-de la Garza RJ; Garcia-Arellano G; Cardenas-de la Garza JA; Aguilar-Rivera LR; de Leon-Perez AA; Aguilar-Rivera E; Vazquez-Perez CE; Galarza-Delgado DA; Esquivel-Valerio JA
Rheumatol Int; 2024 May; 44(5):831-837. PubMed ID: 37610651
[TBL] [Abstract][Full Text] [Related]
11. The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method.
Yajima N; Tsujimoto Y; Fukuma S; Sada KE; Shimizu S; Niihata K; Takahashi R; Asano Y; Azuma T; Kameda H; Kuwana M; Kohsaka H; Sugiura-Ogasawara M; Suzuki K; Takeuchi T; Tanaka Y; Tamura N; Matsui T; Mimori T; Fukuhara S; Atsumi T
Mod Rheumatol; 2020 May; 30(3):525-531. PubMed ID: 31111758
[No Abstract] [Full Text] [Related]
12. Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study.
Fasano S; Coscia MA; Pierro L; Ciccia F
Lupus; 2021 May; 30(6):991-997. PubMed ID: 33709836
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Zen M; Saccon F; Gatto M; Montesso G; Larosa M; Benvenuti F; Iaccarino L; Doria A
Rheumatology (Oxford); 2020 Jul; 59(7):1591-1598. PubMed ID: 31642908
[TBL] [Abstract][Full Text] [Related]
14. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.
Mosca M; Tani C; Aringer M; Bombardieri S; Boumpas D; Brey R; Cervera R; Doria A; Jayne D; Khamashta MA; Kuhn A; Gordon C; Petri M; Rekvig OP; Schneider M; Sherer Y; Shoenfeld Y; Smolen JS; Talarico R; Tincani A; van Vollenhoven RF; Ward MM; Werth VP; Carmona L
Ann Rheum Dis; 2010 Jul; 69(7):1269-74. PubMed ID: 19892750
[TBL] [Abstract][Full Text] [Related]
15. Low-dose glucocorticoids should be withdrawn or continued in systemic lupus erythematosus? A systematic review and meta-analysis on risk of flare and damage accrual.
Ji L; Xie W; Zhang Z
Rheumatology (Oxford); 2021 Dec; 60(12):5517-5526. PubMed ID: 33576768
[TBL] [Abstract][Full Text] [Related]
16. Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.
Sreedharan S; Li N; Littlejohn G; Buchanan R; Nikpour M; Morand E; Hoi A; Golder V
Arthritis Res Ther; 2022 Jun; 24(1):150. PubMed ID: 35733186
[TBL] [Abstract][Full Text] [Related]
17. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
Tsang-A-Sjoe MW; Bultink IE; Heslinga M; Voskuyl AE
Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
19. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae SC; Boletis J; Bruce IN; Cervera R; Doria A; Dörner T; Furie RA; Gladman DD; Houssiau FA; Inês LS; Jayne D; Kouloumas M; Kovács L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT
Ann Rheum Dis; 2024 Jan; 83(1):15-29. PubMed ID: 37827694
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines.
Tunnicliffe DJ; Singh-Grewal D; Kim S; Craig JC; Tong A
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1440-52. PubMed ID: 25778500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
